Chemical approaches to bacterial vaccines. Synthesis of mycobacterial oligosaccharide-protein conjugates for use as serodiagnostics and immunogens

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 12, 1996, Pages 1387-1392

  Dubois, Eric P ^a   Robbins, John B ^a   Pozsgay, Vince ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; MYCOBACTERIUM ANTIGEN; SERUM ALBUMIN;

ARTICLE; COVALENT BOND; DRUG CONJUGATION; DRUG SYNTHESIS; GLYCOSYLATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0029893525     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00235-1     Document Type: Article

References (26)

1. (a) Snider, D. E. Rev. Infect. Dis. 1989, 11, Suppl. 2, S336.
2. (b) Kochi, A. Tubercle, 1991, 72, 1.
3. (c) Bull. W. H. O. 1992, 70, 17.
4. Raviglione, M. C.; Snider, D. E.; Kochi, A. J. Am. Med. Ass. 1995, 273, 220.
5. Fine, P. E. Rev. Infect. Dis. 1989, 12, 353.
6. For a recent review, see: Cooper, A. M.; Flynn, J. L. Current Opinion in Immunology 1995, 7, 512.
7. Coates, S. R.; Hansen, D.; Schechter, G.; Slutkin, G.; Hopewell, P.; Affronti, L.; Echenberg, D. F. J. Clin. Microbiol. 1986, 24, 126.
8. Kent, P. W. J. Chem. Soc., 1951, 364.
9. Pozsgay, V.; Robbins, J. B. Carbohydr. Res. 1995, 277, 51.
10. Pozsgay, V.; Coxon, B. Carbohydr. Res. 1995, 277, 171.
11. Unpublished results from this laboratory.
12. For a related observation, see: Zhang, Y.; Brodzky, A.; Sinaÿ, P.; Saint-Marcoux, G.; Perly, B. Tetrahedron: Asymmetry 1995, 6, 1195.
13. 2C].
14. For a review on cyclic acetals of, see: A. N. DeBelder Adv. Carbohydr. Chem. Biochem. 1977, 34, 179.
15. 1,2 ∼ 3 Hz, corresponding to the a anomer, after spontaneous anomerization (approx. 30 min).
16. Protection of vicinal trans 1,2-diol systems as cyclohexane-1,2-diacetals in thioglycoside donors were described: (a) Ley, S. V.; Priepke, H. W. M.; Warriner, S. L. Angew. Chem. Int. Ed. Engl. 1994, 33, 2290.
17. (b) Ley, S. V.; Priepke, H. W. M. ibid. 1994, 33, 2292.
18. (c) Edwards, P. J.; Entwistle, D. A.; Genicot, C.; Ley, S. V.; Visentin, G. Tetrahedron: Asymmetry 1994, 5, 2609. In these systems the fused dioxane ring is highly stable and its removal requires robust acidic conditions.
19. Sabesan, S.; Paulson, J. C. J. Am. Chem. Soc. 1986, 108, 2068.
20. Zemplén, G.; Pacsu, E. Ber. Dtsch. Chem. Ges. 1929, 62, 1613.
21. Chu, C. Y.; Schneerson, R.; Robbins, J. B.; Rastogi, S. C. Infect. Immun. 1983, 40, 245.
22. (a) Inman, J. K.; Merchant, B.; Claflin, L.; Tacey, S. E. Immunochemistry, 1973, 10, 165.
23. (b) Lemieux, R. U.; Bundle, D. R.; Baker, D. A. J. Am. Chem. Soc. 1975, 96, 4076.
24. (c) Lemieux, R. U.; Baker, D. A.; Bundle, D. R. Can. J. Biochem. 1977, 55, 507.
25. Pinto, B. M.; Bundle, D. R. Carbohydr. Res. 1983, 124, 313.
26. Dai, Z. D.; Morris, S.; Muller, J.; Schulz, D.; Pozsgay, V.; Schneerson, R.; Robbins, J. B. Manuscript in preparation.